Neuropsychiatric Manifestations of Wilson Disease: Correlation with MRI and Glutamate Excitotoxicity
- PMID: 34435331
- DOI: 10.1007/s12035-021-02525-4
Neuropsychiatric Manifestations of Wilson Disease: Correlation with MRI and Glutamate Excitotoxicity
Abstract
This study aims to identify neuropsychiatric manifestations in neurological Wilson disease (NWD), and their correlation with MRI changes and glutamate excitotoxicity. Forty-three consecutive patients with NWD from a tertiary care teaching hospital were evaluated prospectively who fulfilled the inclusion criteria. The neuropsychiatric evaluation was done using Neuropsychiatric Inventory (NPI) battery that assesses 12 domains including delusion, hallucination, agitation/aggression, dysphoria/depression, anxiety, euphoria, apathy, disinhibition, irritability, aberrant motor activity, appetite change, and abnormal nighttime behavior. Cranial MRI was done using a 3 T machine, and locations of signal changes were noted including the total number of MRI lesions. Serum glutamate level was measured by a fluorescence microplate reader. Abnormal NPI in various domains and total NPI scores were correlated with MRI lesions, serum and urinary copper, and glutamate level. The median age of the patients was 16 years. Forty-one (48.8%) patients had cognitive impairment and 37 (86%) had movement disorder. Neurobehavioral abnormality was detected in all-commonest being agitation (90.7%) followed by appetite change (81.4%), elation (74.4%), irritability (69.8%), anxiety (67.4%), depression (65.1%), apathy (44.2%), night time abnormal behavior (32.6%), aberrant motor behavior (20.9%), delusions (16.3%), and hallucination (18.6%). The thalamic lesion was associated with depression, globus pallidus with depression and anxiety, caudate with anxiety and agitation, brainstem with irritability, and frontal cortex with apathy. Serum glutamate level was higher in NWD. NPI sum score correlated with MRI load and glutamate level. Varying severity of neurobehavioral abnormalities are common in the patients with NWD and correlate with the location of MRI lesion and glutamate level.
Keywords: Anxiety; Delusion; Depression; Glutamate; Hallucination; Irritability; MRI; Wilson disease; Copper; Neuropsychiatric inventory.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Movement Disorder in Wilson Disease: Correlation with MRI and Biomarkers of Cell Injury.J Mol Neurosci. 2021 Feb;71(2):338-346. doi: 10.1007/s12031-020-01654-0. Epub 2020 Jul 13. J Mol Neurosci. 2021. PMID: 32662046
-
The association between cognitive impairment and neuropsychiatric symptoms in patients with Parkinson's disease dementia.Int Psychogeriatr. 2012 Dec;24(12):1980-7. doi: 10.1017/S1041610212001317. Epub 2012 Jul 27. Int Psychogeriatr. 2012. PMID: 22835209
-
Neuropsychiatric manifestations of multiple sclerosis.J Neuropsychiatry Clin Neurosci. 1999 Winter;11(1):51-7. doi: 10.1176/jnp.11.1.51. J Neuropsychiatry Clin Neurosci. 1999. PMID: 9990556
-
The Neuropsychiatric Inventory: assessing psychopathology in dementia patients.Neurology. 1997 May;48(5 Suppl 6):S10-6. doi: 10.1212/wnl.48.5_suppl_6.10s. Neurology. 1997. PMID: 9153155 Review.
-
Prevalence of Behavioral and Psychological Symptoms of Dementia in Community-Dwelling Dementia Patients: A Systematic Review.Front Psychiatry. 2021 Oct 21;12:741059. doi: 10.3389/fpsyt.2021.741059. eCollection 2021. Front Psychiatry. 2021. PMID: 34744832 Free PMC article.
Cited by
-
Long-term outcome of patients with neurological form of Wilson's disease compliant to the de-coppering treatment.J Neurol. 2023 Jul;270(7):3492-3498. doi: 10.1007/s00415-023-11681-7. Epub 2023 Apr 5. J Neurol. 2023. PMID: 37016067
-
Macrothrombocytopenia with leukocyte inclusions in a patient with Wilson disease: a case report and literature review.BMC Med Genomics. 2024 Jul 17;17(1):188. doi: 10.1186/s12920-024-01960-1. BMC Med Genomics. 2024. PMID: 39020387 Free PMC article. Review.
-
Brain Magnetic Resonance Imaging in Wilson's Disease-Significance and Practical Aspects-A Narrative Review.Brain Sci. 2024 Jul 19;14(7):727. doi: 10.3390/brainsci14070727. Brain Sci. 2024. PMID: 39061467 Free PMC article. Review.
-
The Glutamatergic Effects of Clinical Repetitive Transcranial Magnetic Stimulation in Depressed Populations: A Preliminary Meta-Analysis of Proton Magnetic Resonance Spectroscopy Studies.Psychopathology. 2024 Jul 12:1-16. doi: 10.1159/000538690. Online ahead of print. Psychopathology. 2024. PMID: 39004073
-
Blood Based Biomarkers of Central Nervous System Involvement in Wilson's Disease.Diagnostics (Basel). 2023 Apr 26;13(9):1554. doi: 10.3390/diagnostics13091554. Diagnostics (Basel). 2023. PMID: 37174946 Free PMC article. Review.
References
-
- Thomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW (1995) The Wilson disease gene: spectrum of mutations and their consequences. Nat Genet 9(2):210–217. https://doi.org/10.1038/ng0295-210 - DOI - PubMed
-
- Ferenci P (2006) Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing. Hum Genet 120(2):151–159. https://doi.org/10.1007/s00439-006-0202-5 - DOI - PubMed
-
- Sandahl TD, Laursen TL, Munk DE, Vilstrup H, Weiss KH, Ott P (2020) The prevalence of Wilson’s disease: an update. Hepatology 71(2):722–732. https://doi.org/10.1002/hep.30911 - DOI - PubMed
-
- Czlonkowska A, Litwin T, Dusek P, Ferenci P, Lutsenko S, Medici V, Rybakowski JK, Weiss KH, et al (2018) Wilson disease. Nat Rev Dis Prim 4(1):21. https://doi.org/10.1038/s41572-018-0018-3 - DOI - PubMed
-
- European Association for Study of L (2012) EASL Clinical Practice Guidelines: Wilson’s disease. J Hepatol 56(3):671–685. https://doi.org/10.1016/j.jhep.2011.11.007 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical